16 July 2026

Honouring the Legacy of Susumu Tonegawa

To us, Tonegawa was not only a giant of world science, he was also a cherished friend of the Champalimaud  Foundation.

Present from the Champalimaud Foundation's earliest and most formative years, he helped shape its scientific DNA, contributing to the model that continues to guide us today: science that is ambitious, rigorous and committed to making a real difference to people's lives. 

15 July 2026

[ robotic surgery room ]

The Robotic Surgery Room combines advanced technology and specialised clinical expertise to support the treatment of cancer patients with exceptional precision and control.

Equipped with a state-of-the-art robotic surgical system, this space enables highly trained surgeons to perform complex surgeries with enhanced accuracy, helping to optimize tumour removal while preserving healthy tissue whenever possible.

08 Jul. 2026

Cell and Organoid Culture Research Technician (Botton-Champalimaud Pancreatic Cancer Centre)

Research
Application Starts: 08 Jul. 2026

 

Offer Description

Seeking a dedicated Cell Culture Research Technician to join our dynamic team to advance medical knowledge and make a positive impact on healthcare.

Main duties will include: 

06 Jul. 2026

Postdoctoral Researcher – Generative AI Agents (SCOPE Lab)

Research
Application Starts: 06 Jul. 2026

 

Offer Description

The Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Postdoctoral Researcher to join the Surgery, Care, Outcomes, Personalization, and Empowerment (SCOPE) Lab, within the Breast Cancer Research Programme.
 

Pathology Updates Course 2026

The Champalimaud Foundation is excited to announce the upcoming course, Pathology Updates 2026, which will be held on September 21st-23rd in the Seminar Room. This course is organised in partnership with Mayo Clinic Scottsdale and Rochester. The 2026 edition marks its 6th iteration and the 3rd to be hosted at the Champalimaud Foundation.

06 July 2026

Improving breast surgery accuracy through patient-specific digital twins

Published in The Breast, the technical pilot study describes the development and feasibility of an augmented reality-guided system for non-invasive tumour localisation. The work is the result of several years of research led by Tiago Marques, Pedro Gouveia and João Santinha, Group Leaders of the Digital Surgery Lab (DSL) together with several team members such as the PhD student Rafaela Timóteo who helped on the project development as well as data acquisition and analysis.

Lymphatic regulation of germinal center dynamics

Host

Carlos Minutti, PhD, Immunoregulation Lab


Venue

Seminar Room

26 June 2026

Celebrating five editions of Ciência di Noz Manera

Since 2021, CNM has been fostering scientific curiosity, confidence and empowerment among students from underserved communities across the Greater Lisbon area through hands-on experiences, meaningful interactions with researchers and sustained mentoring relationships. 

17 June 2026

Honouring a surgical pioneer: celebrating Professor Bill Heald and 50 years of TME at the Champalimaud Foundation

A legacy that changed rectal cancer

When Professor Heald first described TME, local recurrence rates after rectal cancer surgery in many centres were 20-30%, with devastating consequences for patients. By insisting on meticulous, sharp dissection in the “holy plane”, respecting embryology and removing the mesorectum as an intact package, he showed that local recurrence could be reduced to single digits, with corresponding gains in survival and function.

12 June 2026

The Champalimaud Foundation welcomed Würth Group representatives for follow‑up visit on Pancreatic Cancer Research Programme

The delegation was composed of Maria Würth, granddaughter of Prof. Reinhold Würth and Executive Vice President of the Würth Group for Arts and Culture, accompanied by her husband, who met with the Champalimaud Foundation’s leadership and the directors of the clinical and scientific teams to review progress and discuss next steps for this long‑term collaboration.

Subscribe to Cancer
Loading
Please wait...